Suppr超能文献

乳腺钼靶钙化可预测接受保乳手术治疗的乳腺癌女性的预后。

Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery.

作者信息

Qi Xiaomin, Chen Aoxiang, Zhang Pei, Zhang Wei, Cao Xuchen, Xiao Chunhua

机构信息

First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, P.R. China.

Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China.

出版信息

Oncol Lett. 2017 Jul;14(1):79-88. doi: 10.3892/ol.2017.6112. Epub 2017 May 3.

Abstract

The impact of calcification in patients with breast carcinoma treated with breast-conserving surgery (BCS) is unclear. The present study aimed to determine the outcome of breast cancer patients with calcification treated with BCS. The records of 409 patients with breast carcinoma treated with BCS from January 2005 to December 2008 were reviewed. Patients were categorized as those with calcification (on mammography or ultrasonography), or those without calcification (neither on mammography nor ultrasonography). The local relapse free survival time (LRFS), disease free survival time (DFS) and overall survival time (OS) were compared, and subgroup analysis was performed based on morphological types and distribution patterns of mammographic calcification. Survival analysis demonstrated that patients with calcification had a significantly increased risk of local recurrence, distant metastasis and mortality compared with those without calcification [relative risk (RR) and 95% confidence interval (CI): local recurrence, 2.46 and 1.11-5.44; distant metastasis, 2.24 and 1.19-4.24; mortality, 2.50 and 1.06-5.86]. Subgroup analysis revealed that the distribution patterns (rather than morphological types of calcification) accounted for the increased risk of recurrence following BCS. Patients with mammographic calcification of liner/segmental distribution had significantly decreased LRFS (RR=6.20; 95% CI, 2.26-16.98), DFS (RR=6.81; 95% CI, 2.86-16.20) and OS (RR=9.14; 95% CI, 2.53-33.00), while patients with mammographic calcification of clustered distribution did not have significantly decreased LRFS, DFS and OS (P>0.05), compared with those without calcification. In addition, the mammographic calcification spreading along the ducts was more likely to be accompanied by an extensive intraductal component (P<0.001). Finally, the outcome of patients with calcification on breast ultrasound was as good as those without calcification. Patients with mammographic calcification, particularly those with calcification spreading along the ducts, have a higher risk of recurrence following BCS, which has a negative impact on long-term survival. Calcification identified on breast ultrasonography does not affect the survival of patients treated with BCS.

摘要

保乳手术(BCS)治疗的乳腺癌患者中钙化的影响尚不清楚。本研究旨在确定接受BCS治疗的有钙化的乳腺癌患者的预后。回顾了2005年1月至2008年12月期间409例行BCS治疗的乳腺癌患者的记录。患者被分为有钙化(乳腺X线摄影或超声检查发现)和无钙化(乳腺X线摄影和超声检查均未发现)两组。比较局部无复发生存时间(LRFS)、无病生存时间(DFS)和总生存时间(OS),并根据乳腺X线钙化的形态类型和分布模式进行亚组分析。生存分析表明,与无钙化患者相比,有钙化患者局部复发、远处转移和死亡风险显著增加[相对风险(RR)及95%置信区间(CI):局部复发,2.46及1.11 - 5.44;远处转移,2.24及1.19 - 4.24;死亡,2.50及1.06 - 5.86]。亚组分析显示,分布模式(而非钙化的形态类型)是BCS后复发风险增加的原因。乳腺X线钙化呈线性/节段性分布的患者LRFS(RR = 6.20;95% CI,2.26 - 16.98)、DFS(RR = 6.81;95% CI,2.86 - 16.20)和OS(RR = 9.14;95% CI,2.53 - 33.00)显著降低,而乳腺X线钙化呈簇状分布的患者与无钙化患者相比,LRFS、DFS和OS无显著降低(P > 0.05)。此外,沿导管扩散的乳腺X线钙化更可能伴有广泛的导管内成分(P < 0.001)。最后,乳腺超声有钙化的患者预后与无钙化患者一样好。乳腺X线摄影有钙化的患者,尤其是沿导管扩散的钙化患者,BCS后复发风险更高,对长期生存有负面影响。乳腺超声发现的钙化不影响接受BCS治疗患者的生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f887/5494880/fe50c1e9d2e1/ol-14-01-0079-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验